Bottom line
GGHCX vs AHSZX: the short answer
GGHCX (INVESCO Health Care Fund) and AHSZX (Alger Health Sciences Fund) are quite different portfolios: only about 34% of their top holdings (by weight) are shared.
AHSZX is cheaper at 0.76% vs 1.07% — a difference of $31 a year per $10,000 invested.
Over five years, GGHCX returned +2.6% a year vs −1.6% for AHSZX.
GGHCX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
GGHCX vs AHSZX side by side
| GGHCX | AHSZX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Invesco | Alger |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.07% | 0.76% |
| Annual cost per $10k | $107 | $76 |
| 10-yr cost on $10k (prospectus) | $1,784 | $1,004 |
| Max front load | 5.5% | — |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +9.2% | +10.6% |
| 5-yr return (annualized) | +2.6% | −1.6% |
| 10-yr return (annualized) | +5.8% | +7.8% |
| Best quarter | +19.6% | +24.6% |
| Worst quarter | −16.5% | −18.6% |
| Net assets (fund) | $1.2B | $75.4M |
| Number of holdings | 82 | 55 |
| Portfolio turnover | 59% | 289% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GGHCX | AHSZX | Difference |
|---|---|---|---|
| 2025 | +15.5% | +10.6% | +4.9% |
| 2024 | +4.0% | +1.6% | +2.4% |
| 2023 | +3.1% | −3.9% | +7.0% |
| 2022 | −13.5% | −16.7% | +3.2% |
| 2021 | +12.2% | +2.8% | +9.4% |
| 2020 | +14.5% | +31.5% | −17.0% |
| 2019 | +32.0% | +22.4% | +9.6% |
| 2018 | +0.5% | +6.2% | −5.7% |
| 2017 | +15.5% | +37.7% | −22.3% |
| 2016 | −11.7% | −2.9% | −8.9% |
Source: Fund prospectus bar charts
Holdings overlap
9 of GGHCX's top 25 holdings also appear in AHSZX's top 25.
| Holding | GGHCX | AHSZX |
|---|---|---|
| Eli Lilly and Co. | 10.59% | 3.29% |
| Johnson & Johnson | 6.76% | 4.06% |
| UnitedHealth Group Inc. | 6.17% | 3.61% |
| Merck & Co., Inc. | 4.59% | 4.18% |
| CVS Health Corp. | 2.52% | 3.67% |
| Welltower Inc. | 2.34% | 4.12% |
| Guardant Health, Inc. | 2.04% | 1.81% |
| Vertex Pharmaceuticals Inc. | 2.01% | 1.80% |
| Thermo Fisher Scientific Inc. | 1.55% | 4.00% |
Source: SEC Form N-PORT
GGHCX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
AHSZX top 10
- Dreyfus Treasury Obligations Cash Management — 6.51%
- Impulse Dynamics Ireland — 4.27%
- Merck & Company Inc — 4.18%
- Welltower Inc — 4.12%
- Johnson & Johnson — 4.06%
- Thermo Fisher Scientific Inc — 4.00%
- Bruker Corp — 3.98%
- Illumina Inc — 3.95%
- Cvs Health Corp — 3.67%
- Unitedhealth Group Inc — 3.61%
FAQ
What is the difference between GGHCX and AHSZX?
Which is cheaper, GGHCX or AHSZX?
Should I own both GGHCX and AHSZX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.